Chapter 33: Geoepidemiology of myasthenia gravis

被引:51
作者
Meyer, Avraham
Levy, Yair [1 ]
机构
[1] Meir Med Ctr, Dept Med E, Kefar Sava, Israel
关键词
Myasthenia gravis; Epidemiology; Environmental factors; Autoantibodies to acetylcholine receptor; EPIDEMIOLOGY; DISEASE; REACTIVITY; PROVINCE;
D O I
10.1016/j.autrev.2009.11.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myasthenia gravis (MG) is an autoimmune disease that affects the post-synaptic area of the neuromuscular junction. Its hallmark is weakness that worsens with activity. MG incidence is rising in the recent decades, mostly the late onset subtype, which is considered to be due to the aging population or unknown environmental factors. The disease has several subtypes which defer slightly in the clinical characteristics, immunological markers, population distribution and the suitable treatments. The autoimmune nature of the disease is manifested by a decrease in the number of acetylcholine receptors in the muscle receptors which makes the endplate potential to be lower than the threshold needed to activate muscle fiber action potential. In our review we try to find the environmental influence on the disease. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:A383 / A386
页数:4
相关论文
共 36 条
[1]   Myasthenia gravis -: A higher than expected incidence in the elderly [J].
Aragonès, JM ;
Bolíbar, L ;
Bonfill, X ;
Bufill, E ;
Mummany, A ;
Alonso, F ;
Illa, I .
NEUROLOGY, 2003, 60 (06) :1024-1026
[2]   MYASTHENIA-GRAVIS - POPULATION DIFFERENCES IN DISEASE EXPRESSION AND ACETYLCHOLINE-RECEPTOR ANTIBODY-TITERS BETWEEN CHINESE AND CAUCASIANS [J].
CHIU, HC ;
VINCENT, A ;
NEWSOMDAVIS, J ;
HSIEH, KH ;
HUNG, TP .
NEUROLOGY, 1987, 37 (12) :1854-1857
[3]  
CHRISTENSEN PB, 1995, ACTA NEUROL SCAND, V91, P192
[4]   More evidence for the association between statins and myasthenia gravis [J].
De Sousa, Eduardo ;
Howard, James .
MUSCLE & NERVE, 2008, 38 (03) :1085-1086
[5]   MEDICAL PROGRESS - MYASTHENIA-GRAVIS [J].
DRACHMAN, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (25) :1797-1810
[6]   Myasthenia gravis - Another autoimmune disease associated with hepatitis C virus infection [J].
Eddy, S ;
Wim, R ;
Peter, V ;
Tanja, R ;
Jan, T ;
Werner, V .
DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (01) :186-189
[7]   Role of immunologic cross-reactivity in neurological diseases [J].
Ercolini, AM ;
Miller, SD .
NEUROLOGICAL RESEARCH, 2005, 27 (07) :726-733
[8]   Epidemiology of neuroimmunological diseases [J].
Flachenecker, Peter .
JOURNAL OF NEUROLOGY, 2006, 253 :2-8
[9]   Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia [J].
Fujimaki, K ;
Takasaki, H ;
Koharazawa, H ;
Takabayashi, M ;
Yamaji, S ;
Baba, Y ;
Kanamori, H ;
Ishigatsubo, Y .
LEUKEMIA & LYMPHOMA, 2005, 46 (07) :1101-1102
[10]   Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis [J].
Gajdos, P ;
Chevret, S ;
Clair, B ;
Tranchant, C ;
Chastang, C .
ANNALS OF NEUROLOGY, 1997, 41 (06) :789-796